Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: Results of a phase 3b, multicenter, randomized, placebo-controlled, double-blind study
Abby S. Van Voorhees, Linda Stein Gold, Mark Lebwohl, Bruce Strober, Charles Lynde, Stephen K. Tyring, Ashley Cauthen, Howard Sofen, Zuoshun Zhang, Maria Paris, Yao Wang
Topics & Concepts
MedicineApremilastScalpPlaceboDermatologyMulticenter studyDouble blindPsoriasisRandomized controlled trialAdverse effectMulticenter trialSurgeryInternal medicinePathologyAlternative medicinePsoriatic arthritisPsoriasis: Treatment and PathogenesisSpondyloarthritis Studies and TreatmentsDermatology and Skin Diseases